Leslie Coolidge and Rob Costantino Join PetVivo Holdings, Inc. Board of Directors
August 01 2022 - 7:00AM
PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company")
an emerging biomedical device company focused on the
commercialization of innovative medical therapeutics for companion
animals and animal athletes is pleased to announce that Rob
Costantino and Leslie Coolidge have joined the Company’s Board of
Directors.
"We are thrilled to welcome Rob and Leslie to
PetVivo’s Board of Directors” said John Lai, Chief Executive
Officer of PetVivo Holdings, Inc. “Rob and Leslie bring a wealth of
business and governance experience to our Company. We anticipate
that their addition to the board will provide us the knowledge and
expertise that will guide our Company to attain the resources and
industry relationships necessary for success."
Mr. Costantino is a retired CPA and former
senior executive who has served as Chief Executive Officer, Chief
Operating Officer and Chief Financial Officer of large
corporations. He is currently a part time financial consultant,
investor and a current member of the Board of Directors of 4 Yamaha
Motor Finance subsidiaries. His most recent executive position was
a dual role of Senior Executive Vice President – Chief Financial
Officer and Chief Operating Officer of NASDAQ listed WFS Financial,
Inc., an automotive and commercial finance company and concurrently
as Executive Vice President – Chief Financial Officer and Chief
Operating Officer of NYSE listed Westcorp, Inc, an OTS regulated
bank. He was responsible for operations and all financial areas
including SEC filings, analyst interaction, earnings calls, and
treasury of both companies. Mr Costantino played a key role in the
negotiation and ultimate sale of both companies to Wachovia (Wells
Fargo) for $3.9 billion. Prior to that, he was President & CEO
and member of the Board of Directors of Mitsubishi Motors Credit of
America, Inc - an automotive finance company with over $10 billion
in assets, where he is credited with one of the greatest
turnarounds in captive finance industry history taking the company
from extreme financial losses to profitability and ultimately
negotiating the sale of the company’s assets to Merrill Lynch.
Prior to that, he served for 17 yrs at various escalating
management positions of Volvo Cars of North America including the
unique experience of being SVP & CFO of both the automotive
parent company and the captive finance company. He was integral to
the successful relocation of the company from the East Coast to CA,
as part of the creation of the Premier Auto Group after Ford Motor
Company acquired Volvo. Mr Costantino’s long successful experiences
in many senior executive positions, CPA, public company experience
and finance background including executing billions of dollars of
asset backed security transactions, as well as multi-billion dollar
asset and entire company sales are material factors regarding his
qualifications to serve on our Board of Directors.
“I am extremely excited to be joining such an
innovative company with disruptive technology in the animal health
market and beyond at this pivotal moment in its history.” said Rob
Costantino. “With each of my meetings with management and members
of the Board of Directors, I became more convinced that PetVivo is
ready to launch to new heights and believe I can make valuable
contributions on their Board. I am absolutely thrilled to be
appointed to the PetVivo Board of Directors and can’t wait to get
to work with these visionary company leaders.”
Ms. Coolidge served as a director of Power
Solutions International, Inc. where she chaired that company’s
Audit Committee. She retired as an Audit and SEC Reviewing Partner
from KPMG LLP. At KPMG, Ms. Coolidge led significant global audit
engagements, serving major companies with their complex accounting,
financial and strategic needs. During her 28 years at KPMG, Ms.
Coolidge led client engagement teams auditing SEC registrants and
concurrently served as concurring reviewing partner. In addition to
her client engagements, she served as a partner in KPMG’s
Department of Professional Practice as well as the firm’s
representative on the American Institute of CPAs’ (“AICPA”)
Accounting Standards Executive Committee. Ms. Coolidge serves on
the Board of the Chicago Academy of Sciences and its Peggy
Notebaert Nature Museum. Ms. Coolidge holds a Bachelor of Arts
degree in Government from Harvard University and a Master of
Science degree in Accounting from New York University. Ms. Coolidge
qualifies as an “Audit Committee Financial Expert” under applicable
SEC regulations and has substantial public company audit experience
gained from her tenure as a partner at KPMG. Ms. Coolidge brings to
the Board a wealth of experience and knowledge of public company
financial reporting and accounting and her experience at the
highest levels of a Big Four accounting firm is an invaluable
resource to the Board in its oversight of the Company’s financial
statements and SEC filings.
“I’ve always believed that technology has the
potential to create a better quality of life for people and
animals,” said Leslie Coolidge. “It’s an honor to be part of a
technology company introducing an innovative medical device that
addresses the cause of an affliction, rather than simply treating
the symptoms.”
About PetVivo Holdings,
Inc.
PetVivo Holdings Inc. (NASDAQ: PETV) is an
emerging biomedical device company currently focused on the
manufacturing, commercialization and licensing of innovative
medical devices and therapeutics for companion animals. The
Company's strategy is to leverage human therapies for the treatment
of companion animals in a capital and time efficient way. A key
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for
the treatment of animals and people. A portfolio of nineteen
patents protects the Company's biomaterials, products, production
processes and methods of use. The Company’s lead product SPRYNG™
with OsteoCushion™ technology, a veterinarian-administered,
intraarticular injection for the management of lameness and other
joint related afflictions, including osteoarthritis, in dogs and
horses, is currently available for commercial sale.
For more information about PetVivo Holdings,
Inc. and our revolutionary product, Spryng with OsteoCushion
Technology, please contact info1@petvivo.com or visit
https://petvivo.com/
CONTACT:
John Lai, CEO
PetVivo Holdings, Inc.
Email: info1@petvivo.com
(952) 405-6216
Forward-Looking commercial Statements:
The foregoing material may contain
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, each as amended. Forward-looking statements
include all statements that do not relate solely to historical or
current facts, including without limitation the Company’s proposed
development and commercial timelines, and can be identified by the
use of words such as “may,” “will,” “expect,” “project,”
“estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,”
“continue” or the negative versions of those words or other
comparable words. Forward-looking statements are not guarantees of
future actions or performance. These forward-looking statements are
based on information currently available to the Company and its
current plans or expectations and are subject to a number of
uncertainties and risks that could significantly affect current
plans. Risks concerning the Company’s business are described in
detail in the Company’s Annual Report on Form 10-K for the year
ended March 31, 2022 and other periodic and current reports filed
with the Securities and Exchange Commission. The Company is under
no obligation to, and expressly disclaims any such obligation to,
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
- PetVivo Holdings, Inc.
- PetVivo Holdings, Inc.
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Aug 2024 to Sep 2024
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Sep 2023 to Sep 2024